Macrogenics MGNX
NASDAQ MGNX
$3.85 +0.08 (+2.12%)
As of: Sep 30, 2026 · 3:59 PM EDT

Macrogenics (MGNX) EV to CFO (2014 - 2023)

Updated

Macrogenics' EV to CFO came in at 44.74 for Q2 2023.

Analysis

Macrogenics (MGNX) EV to CFO (2014 - 2023) Analysis & Trends

Over the trailing twelve months to Jun 30, 2023, Macrogenics reported EV to CFO of -39.09; for FY2017, it came in at 27.44.

  • The Q2 2023 figure represents the highest quarterly EV to CFO since Q1 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Macrogenics 239.94 Mn -77.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 44.74
Mar 31, 2018 39.64
Dec 31, 2017 27.44
Mar 31, 2015 137.17
Jun 30, 2014 300.54
API Access

Macrogenics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=MGNX&period=max&api_key=YOUR_API_KEY